TransThera Sciences schedules board meeting to review interim resultsPUBT·Aug 14 at 03:58 AM02617-0.67%
TRANSTHERA-B Opens ~15% Higher as Proprietary New Drug 'Yochanra' Approved for Market LaunchAASTOCKS News·Aug 6 at 09:21 PM02617-0.67%
Transthera Sciences files HKEX next-day return disclosing share repurchase for cancellationPUBT·Jul 23 at 07:08 AM02617-0.67%
Transthera Sciences files HKEX next-day disclosure return disclosing share repurchase at HKD 10.91 average pricePUBT·Jul 22 at 06:11 AM02617-0.67%
TransThera Completes Global Phase III Enrollment for Tinengotinib in Advanced CholangiocarcinomaTip Ranks·Jul 1 at 06:38 AM02617-0.67%
TransThera Sciences to Launch Up to RMB100 Million H-Share BuybackTip Ranks·Jun 28 at 05:07 AM02617-0.67%
Southbound Funds Net Bought HK$8.92 Billion This Week; Yaojie Ankang-B Holdings Jumped 142.51%CoinLive·Jun 28 at 02:02 AM06082+6.85%02617-0.67%
